NCT06390124View on ClinicalTrials.gov

Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21)

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

June 5, 2024

Conditions
Peri-Implantitis
Interventions
DRUG

Platelet Derived Growth Factor (PDGF)

Reconstructive therapy of advanced peri-implantitis-related defects with anorganic bovine bone and allograft combined with PDGF

Trial Locations (1)

06011

Centro de Implantologia Cirugia Oral y Maxilofacial, Badajoz

All Listed Sponsors
lead

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

OTHER